-
FDA limits use of two COVID antibody treatments
The U.S. Food and Drug Administration said Monday that it will curtail the use of two monoclonal antibody treatments that... Read more -
Allopurinol not tied to higher mortality for patients with gout and chronic kidney disease
(HealthDay)—For patients with gout and chronic kidney disease (CKD), no associations with increased mortality were seen for allopurinol initiation, achieving... Read more -
An effectiveness study to guide the treatment of depression in adolescents
A study in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP), published by Elsevier, reports that,... Read more -
Research finds that patient out-of-pocket spending increased from 2014-2018 for hepatitis B medication
Recently published in JAMA Network Open, University of Minnesota Medical School researchers found that during a four-year period, patient out-of-pocket... Read more -
Can CBD help curb COVID? Maybe, but more study is needed
Cannabidiol, a compound derived from marijuana, appears to show promise in blocking replication of the COVID-19 virus and preventing its... Read more -
Opioid overdose antidote urged for schools after student's fentanyl death
(HealthDay)—Schools should stock the opioid overdose antidote naloxone and train staff and students how to respond to an overdose, experts... Read more -
FDA may limit use of two COVID antibody treatments
The U.S. Food and Drug Administration may soon curtail the use of two monoclonal antibody treatments that do not appear... Read more -
Combo immunotherapy ups survival in advanced liver cancer
(HealthDay)—STRIDE (Single tremelimumab Regular Interval durvalumab) is proposed as first-line therapy for unresectable hepatocellular carcinoma (uHCC), according to a study... Read more -
Researchers discover way to disarm potentially deadly Listeria bacteria
University of Queensland researchers have unlocked a way of fighting Listeria infections, which can cause severe illness in pregnant women... Read more -
Semaglutide superior to liraglutide for weight loss
(HealthDay)—Among adults with overweight or obesity, once-weekly subcutaneous semaglutide plus counseling for diet and physical activity results in significantly greater... Read more -
Another old drug is being tried against COVID-19, and might actually help
In the first few weeks of the pandemic, when physicians were grappling with the unknown like everyone else, psychiatrist Angela... Read more -
State laws about prescribing may limit access to HIV pre-exposure prophylaxis
State laws in the US that require medical doctors (MDs) to determine which medications a nurse practitioner (NP) or physician... Read more -
Prophylactic antibiotics not needed before invasive dental procedures
(HealthDay)—There is no evidence to support administering antibiotic prophylaxis before invasive dental procedures (IDP) in patients with prosthetic joints, according... Read more -
Trastuzumab with chemoradiation and surgery does not improve outcomes for esophageal cancer patients
The NRG Oncology clinical trial NRG-RTOG 1010, studying the addition of the drug trastuzumab to chemoradiation and surgery, did not... Read more -
Low-cost drug Heparin effective and safe treatment for COVID-19
Heparin, a widely available and affordable drug, has found to limit lung damage when inhaled by COVID-19 patients.... Read more
